Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel

被引:0
|
作者
Hobyung Chung
Masatoshi Kudo
Takashi Kumada
Shinji Katsushima
Akihiro Okano
Takefumi Nakamura
Yukio Osaki
Katsuji Kohigashi
Yukitaka Yamashita
Hideshi Komori
Shinichi Nishiuma
机构
[1] Kinki University School of Medicine,Department of Gastroenterology and Hepatology
[2] Ogaki Municipal Hospital,Department of Gastroenterology
[3] NTT West Osaka Hospital,Department of Gastroenterology and Hepatology
[4] Tenri Hospital,Department of Gastroenterology
[5] Kitano Hospital,Department of Gastroenterology and Hepatology
[6] Osaka Red Cross Hospital,Department of Gastroenterology
[7] Hyogo Prefectural Amagasaki Hospital,Department of Gastroenterology
[8] Kishiwada City Hospital,Department of Gastroenterology and Hepatology
[9] Nishi-Kobe Medical Center,Gastroenterology Division
[10] Kobe City General Hospital,Department of Gastroenterology
[11] Japanese Red Cross Society Wakayama Medical Center,Department of Gastroenterology and Hepatology
来源
关键词
hepatitis C virus; needlestick injury; interferon;
D O I
暂无
中图分类号
学科分类号
摘要
Background. We carried out this study to assess the risk of hepatitis C virus (HCV) transmission after needlestick injuries in medical personnel, and to evaluate the efficacy of short-duration interferon administration to prevent HCV transmission. Methods. A total of 684 personnel who had been occupationally exposed to an anti-HCV-positive source and followed for more than 3 months were retrospectively examined. Results. Of the 684 subjects, 279 (41%) were treated with 1 to 3 days of interferon either just after or 1 to 12 days after the injury. One case of HCV infection was found in each of the treated (1/279; 0.4%) and nontreated (1/405; 0.2%) groups. There was no significant difference in the transmission of HCV between the two groups. Both infected patients were treated with interferon after developing acute hepatitis, and HCV was subsequently cleared. Conclusions. There is a lower risk of HCV transmission after needlestick accident than previously reported, and short-duration interferon administration at an early stage after the needlestick injury, to prevent HCV transmission, is unnecessary.
引用
收藏
页码:877 / 879
页数:2
相关论文
共 16 条
  • [1] Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel
    Chung, H
    Kudo, M
    Kumada, T
    Katsushima, S
    Okano, A
    Nakamura, T
    Osaki, Y
    Kohigashi, K
    Yamashita, Y
    Komori, H
    Nishiuma, S
    JOURNAL OF GASTROENTEROLOGY, 2003, 38 (09) : 877 - 879
  • [2] Triple therapy prevents HIV but not HCV transmission after needlestick injury
    Fabris, P
    Manfrin, V
    Rassu, M
    Tositti, G
    de Lalla, F
    Zanetti, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (07): : 1990 - 1991
  • [3] Transmission of HBV, HCV and HIV by infected medical personnel: a review
    Hasselhorn, HM
    Hofmann, F
    CHIRURG, 2000, 71 (04): : 389 - 395
  • [4] TRANSPLANTATION FROM HCV-INFECTED DONORS TO HCV-UNINFECTED RECIPIENTS: SHORT COURSE THERAPY TO PREVENT TRANSMISSION
    Feld, Jordan J.
    Cypel, Marcelo
    Kumar, Deepali
    Tinckam, Kathryn
    Kim, Joseph
    Schiff, Jeffrey
    McDonald, Michael
    Badiwala, Mitesh
    Reichman, Trevor
    Marks, Nikki
    Bahinskaya, Ilona
    Kamkar, Nellie
    Keshavjee, Shaf
    Singer, Lianne
    Humar, Atul
    HEPATOLOGY, 2019, 70 : 27A - 27A
  • [5] IS THERE RISK OF TRANSMITTING HEPATITIS-C VIRUS FROM HCV+ PATIENTS TO MEDICAL PERSONNEL VIA NEEDLESTICK INJURIES
    BARRIL, G
    NEFROLOGIA, 1995, 15 (03): : 301 - 302
  • [6] Short-Duration Sofosbuvir/Velpatasvir Safe and Effective in Treating HCV Infection Immediately after Liver Transplant
    Gane, Edward J.
    Beckmann, Andrea
    Hyland, Robert
    Arterburn, Sarah
    Svarovskaia, Evguenia
    Massetto, Benedetta
    Brainard, Diana
    Munn, Stephen
    HEPATOLOGY, 2018, 68 : 359A - 359A
  • [7] Prevalence and risk of HCV transmission after screening for HIV and HBV in blood donnors
    Dagnra, A
    Prince-David, A
    Agbénu, S
    Ouro-Akpo, T
    Hounkpati, F
    MEDECINE ET MALADIES INFECTIEUSES, 2002, 32 (06): : 315 - 316
  • [8] Modeling time to cure after short-duration treatment for chronic HCV with daclatasvir, asunaprevir, beclabuvir and sofosbuvir: the FOURward study
    Deng, B.
    Lou, S.
    Dubey, P.
    Etzion, O.
    Chayam, K.
    Uprichard, S. L.
    Sulkowski, M.
    Cotler, S. J.
    Dahari, H.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 58 - 58
  • [9] Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty
    Keeney, James A.
    Clohisy, John C.
    Curry, Madelyn C.
    Maloney, William J.
    JOURNAL OF ARTHROPLASTY, 2006, 21 (04): : 469 - 475
  • [10] Short Duration Perioperative Administration of Ledipasvir/Sofosbuvir Is Safe and Effective in Preventing HCV Recurrence After Liver Transplant.
    Verna, E.
    Levitsky, J.
    O'Leary, J.
    Bzowej, N.
    Moonka, D.
    Hyland, R.
    Brainard, D.
    McHutchison, J.
    Terrault, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 333 - 334